Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 44.85
+0.41 (0.92%)
May 30, 2025, 2:45 PM CST
Hangzhou Biotest Biotech Revenue
Hangzhou Biotest Biotech had revenue of 87.89M CNY in the quarter ending March 31, 2025, a decrease of -35.20%. This brings the company's revenue in the last twelve months to 511.66M, up 7.93% year-over-year. In the year 2024, Hangzhou Biotest Biotech had annual revenue of 559.40M with 26.53% growth.
Revenue (ttm)
511.66M
Revenue Growth
+7.93%
P/S Ratio
9.11
Revenue / Employee
848.53K
Employees
603
Market Cap
4.66B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |